Trial Profile
Impact on Quality of life of patient with hepatocellular carcinoma treated with Sorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Apr 2018 New trial record
- 07 Mar 2018 Results presented at the 16th International Congress on Targeted Anticancer Therapies.